Personensuche

Personensuche

Bitte geben Sie den Namen der gesuchten Person ein.

Es wurde 1 Person gefunden.

Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.

    Artikel in Zeitschriften

  • Fasching, Peter A.; Decker, Thomas; Hartkopf, Andreas; Nusch, Arnd; Heinrich, Bernhard J.; Kurbacher, Christian; Fuchs, Roswitha; Tesch, Hans; Krabisch, Petra; Huober, Jens; Kümmel, Sherko; Brucker, Sara; Janni, Wolfgang; Schneeweiss, Andreas; Schuler, Martin; Fehm, Tanja; Lüftner, Diana; Quiering, Claudia; Voges, Claudia; Kreuzeder, Julia; Reinisch, Mattea
    Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole : Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or metastatic breast cancer
    In: European Journal of Cancer (EJC) Jg. 198 (2024) 113480
  • Harbeck, Nadia; Nitz, Ulrike A.; Christgen, Matthias; Kümmel, Sherko; Braun, Michael; Schumacher, Claudia; Potenberg, Jochem; Tio, Joke; Aktas, Bahriye; Forstbauer, Helmut; Grischke, Eva-Maria; Scheffen, Iris; Malter, Wolfram; von Schumann, Raquel; Just, Marianne; Zu Eulenburg, Christine; Biehl, Claudia; Kolberg-Liedtke, Cornelia; Deurloo, Regula; de Haas, Sanne; Jóźwiak, Katarzyna; Hauptmann, Michael; Kates, Ronald; Graeser, Monika; Wuerstlein, Rachel; Kreipe, Hans H.; Gluz, Oleg
    De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer : 5-Year Survival in the WSG-ADAPT-TP Trial
    In: Journal of Clinical Oncology (JCO) Jg. 41 (2023) Nr. 22, S. 3796 - 3804
  • Pasquier, David; Bidaut, Luc; Oprea-Lager, Daniela Elena; deSouza, Nandita M; Krug, David; Collette, Laurence; Kunz, Wolfgang; Belkacemi, Yazid; Bau, Maria Grazia; Caramella, Caroline; De Geus-Oei, Lioe-Fee; De Caluwé, Alex; Deroose, Christophe; Gheysens, Olivier; Herrmann, Ken; Kindts, Isabelle; Kontos, Michalis; Kümmel, Sherko; Linderholm, Barbro; Lopci, Egesta; Meattini, Icro; Smeets, Ann; Kaidar-Person, Orit; Poortmans, Philip; Tsoutsou, Pelagia; Hajjaji, Nawale; Russell, Nicola; Senkus, Elżbieta; Talbot, Jean-Noël; Umutlu, Lale; Vandecaveye, Vincent; Verhoeff, Joost J C; van Oordt, Willemien Menke-van der Houven; Zacho, Helle D; Cardoso, Fatima; Fournier, Laure; Van Duijnhoven, Frederieke; Lecouvet, Frédéric E
    Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer : a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
    In: The Lancet Oncology Jg. 24 (2023) Nr. 8, S. e331 - e343
  • Graeser, Monika; Gluz, Oleg; Biehl, Claudia; Ulbrich-Gebauer, Daniel; Christgen, Matthias; Palatty, Jenci; Kümmel, Sherko; Grischke, Eva-Maria; Augustin, Doris; Braun, Michael; Potenberg, Jochem; Wuerstlein, Rachel; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; Zu Eulenburg, Christine; Kates, Ronald; Ni, Hua; Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Kreipe, Hans Heinrich; Nitz, Ulrike; Harbeck, Nadia
    Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial
    In: Clinical Cancer Research Jg. 29 (2023) Nr. 4, S. 805 - 814
  • Gluz, O.; Kuemmel, S.; Nitz, U.; Braun, M.; Lüdtke-Heckenkamp, K.; von Schumann, R.; Darsow, M.; Forstbauer, H.; Potenberg, J.; Uleer, C.; Grischke, E.M.; Aktas, B.; Schumacher, C.; zu Eulenburg, C.; Kates, R.; Jóźwiak, K.; Graeser, M.; Wuerstlein, R.; Baehner, R.; Christgen, M.; Kreipe, H.H.; Harbeck, N.
    Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer : results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial
    In: Annals of Oncology Jg. 34 (2023) Nr. 6, S. 531 - 542
  • Degenhardt, Tom; Fasching, Peter A.; Lüftner, Diana; Müller, Volkmar; Thomssen, Christoph; Schem, Christian; Witzel, Isabell; Decker, Thomas; Tesch, Hans; Kümmel, Sherko; Uleer, Christoph; Wuerstlein, Rachel; Hoffmann, Oliver; Warm, Mathias; Marschner, Norbert; Schinköthe, Timo; Kates, Ronald E.; Schumacher, Johannes; Otremba, Burkhard; Zaiss, Matthias; Harbeck, Nadia; Schmidt, Marcus
    PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant
    In: Trials Jg. 24 (2023) Nr. 1, 338
  • Ditsch, Nina; Wöcke, Achim; Untch, Michael; Jackisch, Christian; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja N.; Friedrich, Michael; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Jörg; Huober, Jens; Kreipe, Hans H.; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Kolberg-Liedtke, Cornelia; Loibl, Sibylle; Lüftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schütz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Witzel, Isabell; Müller, Volkmar; Janni, Wolfgang; Thill, Marc
    AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer : Update 2022
    In: Breast Care Jg. 17 (2022) Nr. 4, S. 403 - 420
  • Thill, Marc; Lüftner, Diana; Kolberg-Liedtke, Cornelia; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Jörg; Huober, Jens; Jackisch, Christian; Kreipe, Hans-Heinrich; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Loibl, Sibylle; Lux, Michael; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schütz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell; Wöckel, Achim; Müller, Volkmar; Janni, Wolfgang; Ditsch, Nina
    AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022
    In: Breast Care Jg. 17 (2022) Nr. 4, S. 421 - 429
  • Banys-Paluchowski, Maggie; Thill, Marc; Kühn, Thorsten; Ditsch, Nina; Heil, Jörg; Wöckel, Achim; Fallenberg, Eva; Friedrich, Michael; Sherko, Kümmel; Müller, Volkmar; Janni, Wolfgang; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fasching, Peter; Fehm, Tanja; Gluz, Oleg; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Kolberg-Liedtke, Cornelia; Kreipe, Hans H.; Krug, David; Loibl, Sibylle; Lüftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schütz, Florian; Sinn, H. Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell; Gerber, Bernd
    AGO Recommendations for the Surgical Therapy of Breast Cancer : Update 2022
    In: Geburtshilfe und Frauenheilkunde Jg. 82 (2022) Nr. 10, S. 1031 - 1043
  • Gluz, Oleg; Nitz, Ulrike; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Kümmel, Sherko; Mohammadian, Mohammad Parsa; Gebauer, Daniel; Kates, Ronald; Paré, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Graeser, Monika; Pelz, Enrico; Jóźwiak, Katarzyna; Zu Eulenburg, Christine; Kreipe, Hans Heinrich; Harbeck, Nadia; ADAPT TN investigators
    De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC) : Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
    In: Clinical Cancer Research Jg. 28 (2022) Nr. 22, S. 4995 - 5003
  • Nitz, Ulrike A.; Gluz, Oleg; Kümmel, Sherko; Christgen, Matthias; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Darsow, Maren; Krauss, Katja; Nuding, Benno; Thill, Marc; Potenberg, Jochem; Uleer, Christoph; Warm, Mathias; Fischer, Hans Holger; Malter, Wolfram; Hauptmann, Michael; Kates, Ronald E.; Gräser, Monika; Würstlein, Rachel; Shak, Steven; Baehner, Frederick; Kreipe, Hans H.; Harbeck, Nadia
    Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast Cancer
    In: Journal of Clinical Oncology (JCO) (2022) JCO.21.02759
  • Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Garke, Madlen; Christgen, Matthias; Kates, Ronald; Grischke, Eva Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kümmel, Sherko; Wuerstlein, Rachel; Graeser, Monika; Nitz, Ulrike; Kreipe, Hans; Gluz, Oleg; Harbeck, Nadia
    Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial
    In: Breast Cancer Research Jg. 24 (2022) Nr. 1, 58
  • Peuker, Caroline A.; Yaghobramzi, Sarvenaz; Grunert, Corinna; Keilholz, Luisa; Gjerga, Enio; Hennig, Steffen; Schaper, Sigrid; Na, Il-Kang; Keller, Ulrich; Brucker, Sara; Decker, Thomas; Fasching, Peter; Fehm, Tanja; Janni, Wolfgang; Kümmel, Sherko; Schneeweiss, Andreas; Schuler, Martin; Lüftner, Diana; Busse, Antonia
    Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer : findings from the RIBECCA trial
    In: European Journal of Cancer (EJC) Jg. 162 (2022) S. 45 - 55
  • Thill, Marc; Friedrich, Michael; Kolberg-Liedtke, Cornelia; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva M.; Fasching, Peter A.; Fehm, Tanja; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Jörg; Huober, Jens; Jackisch, Christian; Kreipe, Hans-Heinrich; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Loibl, Sibylle; Lüftner, Diana; Lux, Michael P.; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schütz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell; Wöckel, Achim; Müller, Volkmar; Janni, Wolfgang; Ditsch, Nina
    AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer : Update 2021
    In: Breast Care Jg. 16 (2021) Nr. 3, S. 228 - 235
  • Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Würstlein, Rachel; Kümmel, Sherko; Schumacher, Claudia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Christgen, Matthias; Adams, Jascha; Nitzsche, Henrik; Just, Marianne; Fischer, Hans Holger; Aktas, Bahriye; Potenberg, Jochem; von Schumann, Raquel; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K.; Nitz, Ulrike
    Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes : Combined analysis from the WSG ADAPT subtrials
    In: International Journal of Cancer Jg. 148 (2021) Nr. 10, S. 2614 - 2627
  • Haller, Heidemarie; Choi, Kyung-Eun; Lange, Silke; Kümmel, Sherko; Paul, Anna; Cramer, Holger; Dobos, Gustav; Voiß, Petra
    Effects of an integrative mind-body-medicine group program on breast cancer patients during chemotherapy : An observational study
    In: Current Pharmaceutical Design Jg. 27 (2021) Nr. 8, S. 1112 - 1120
  • Höxtermann, Melanie D.; Buner, Katja; Haller, Heidemarie; Kohl, Wiebke; Dobos, Gustav; Reinisch, Mattea; Kümmel, Sherko; Cramer, Holger; Voiß, Petra
    Efficacy and safety of auricular acupuncture for the treatment of insomnia in breast cancer survivors : A randomized controlled trial
    In: Cancers Jg. 13 (2021) Nr. 16, 4082
  • Grimm, Donata; Voiß, Petra; Paepke, Daniela; Dietmaier, Johanna; Cramer, Holger; Kümmel, Sherko; Beckmann, Matthias W.; Woelber, Linn; Schmalfeldt, Barbara; Freitag, Ulrich; Kalder, Matthias; Wallwiener, Markus; Theuser, Anna-Katharin; Hack, Carolin C.
    Gynecologists’ attitudes toward and use of complementary and integrative medicine approaches : Results of a national survey in Germany
    In: Archives of Gynecology and Obstetrics Jg. 303 (2021) Nr. 4, S. 967 - 980
  • Graeser, Monika; Feuerhake, Friedrich; Gluz, Oleg; Volk, Valery; Hauptmann, Michael; Jozwiak, Katarzyna; Christgen, Matthias; Kümmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kolberg-Liedtke, Cornelia; Kates, Ronald; Wuerstlein, Rachel; Nitz, Ulrike; Kreipe, Hans Heinrich; Harbeck, Nadia
    Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
    In: Journal for ImmunoTherapy of Cancer Jg. 9 (2021) Nr. 5, S. e002198
  • Harbeck, Nadia; von Schumann, Raquel; Kates, Ronald Ernest; Braun, Michael; Kümmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Malter, Wolfram; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva-Maria; Biehl, Claudia; Liedtke, Cornelia; De Haas, Sanne Lysbet; Deurloo, Regula; Wuerstlein, Rachel; Kreipe, Hans Heinrich; Gluz, Oleg
    Immune markers and tumor-related processes predict neoadjuvant therapy response in the wsg-adapt her2-positive/hormone receptor-positive trial in early breast cancer
    In: Cancers Jg. 13 (2021) Nr. 19, 4884
  • Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Herzog, Christopher; Umutlu, Lale; Frydrychowicz, Alex; Rjosk-Dendorfer, Dorothea; Würstlein, Rachel; Culemann, Ralph; Eulenburg, Christine; Adams, Jascha; Nitzsche, Henrik; Prange, Anna; Kümmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Potenberg, Jochem; von Schumann, Raquel; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K.; Nitz, Ulrike
    Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials
    In: Breast Cancer Research Jg. 23 (2021) Nr. 1, 36
  • Klose, Petra; Lange, Silke; Paul, Anna; Kümmel, Sherko; Voiß, Petra; Dobos, Gustav
    Mind-Body-Medizin in der Integrativen Onkologie : Studienlage und Einsatzgebiete
    In: Der Gynäkologe Jg. 54 (2021) Nr. 1, S. 19 - 25
  • Grote, Isabel; Bartels, Stephan; Kandt, Leonie; Bollmann, Laura; Christgen, Henriette; Gronewold, Malte; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Nitz, Ulrike; Kümmel, Sherko; zu Eulenburg, Christine; Braun, Michael; Aktas, Bahriye; Grischke, Eva-Maria; Schumacher, Claudia; Luedtke-Heckenkamp, Kerstin; Kates, Ronald; Wuerstlein, Rachel; Graeser, Monika; Harbeck, Nadia; Christgen, Matthias; Kreipe, Hans
    TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer
    In: Cancer Medicine Jg. 10 (2021) Nr. 23, S. 8581 - 8594
  • Haller, Heidemarie; Voiß, Petra; Cramer, Holger; Paul, Anna; Reinisch, Mattea; Appelbaum, Sebastian; Dobos, Gustav; Sauer, Georg; Kümmel, Sherko; Ostermann, Thomas
    The INTREST registry : Protocol of a multicenter prospective cohort study of predictors of women’s response to integrative breast cancer treatment
    In: BMC Cancer Jg. 21 (2021) Nr. 1, 724
  • Graeser, Monika; Harbeck, Nadia; Gluz, Oleg; Würstlein, Rachel; zu Eulenburg, Christine; Schumacher, Claudia; Grischke, Eva-Maria; Forstbauer, Helmut; Dimpfl, Moritz; Braun, Michael; Christgen, Matthias; Kreipe, Hans Heinrich; Potenberg, Jochem; von Schumann, Raquel; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Kümmel, Sherko; Nitz, Ulrike
    The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
    In: The Breast Jg. 59 (2021) S. 58 - 66
  • Hack, C.C.; Häberle, L.; Brucker, S.Y.; Janni, W.; Volz, B.; Loehberg, C.R.; Hartkopf, A.D.; Walter, C.-B.; Baake, G.; Fridman, A.; Malter, W.; Wuerstlein, R.; Harbeck, N.; Hoffmann, Oliver; Kümmel, Sherko; Martin, B.; Thomssen, C.; Graf, H.; Wolf, C.; Lux, M.P.; Bayer, C.M.; Rauh, C.; Almstedt, K.; Gass, P.; Heindl, F.; Brodkorb, T.; Willer, L.; Lindner, C.; Kolberg, Hans-Christian; Krabisch, P.; Weigel, M.; Steinfeld-Birg, D.; Kohls, A.; Brucker, C.; Schulz, V.; Fischer, G.; Pelzer, V.; Rack, B.; Beckmann, M.W.; Fehm, T.; Rody, A.; Maass, N.; Hein, A.; Fasching, P.A.; Nabieva, N.
    Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
    In: The Breast Jg. 50 (2020) S. 11 - 18
  • Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Paré, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kümmel, Sherko; Wuerstlein, Rachel; Pelz, Enrico; Nitz, Ulrike; Kreipe, Hans Heinrich; Harbeck, Nadia
    Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer : Primary translational analysis of the WSG-ADAPT-TN trial
    In: International Journal of Cancer Jg. 146 (2020) Nr. 1, S. 262 - 271
  • Grote, I.; Bartels, Sanne; Kandt, L.; Bollmann, Laslo; Christgen, Henriette; Gronewold, Malte; Gluz, Oleg; Nitz, Ulrike; Kümmel, Sherko; Braun, M.; Aktas, Bahriye; Grischke, E-M.; Schumacher, Claudia; Lüdtke-Heckenkamp, Kerstin; Kates, R.; Wuerstlein, Rachel; Gräser, Maximilian; Harbeck, Nadja; Christgen, Mathias; Kreipe, Hans
    Impaired Ki67 response towards neoadjuvant endocrine therapy in luminal breast cancer is associated with mutations conferring endocrine resistance : WSG-ADAPT HR+/HER2- translational results
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S306
  • Schmidt, Marcus; Degenhardt, Tom; Fasching, Peter Andreas; Lüftner, Diana I.; Müller, Volkmar; Thomssen, Christoph; Schem, Christian; Witzel, Isabell D.; Decker, Thomas; Tesch, Hans J.; Kümmel, Sherko; Uleer, Christoph; Würstlein, Rachel; Hoffmann, Oliver; Warm, Mathias; Marschner, Norbert W.; Kates, Ronald Ernest; Schumacher, Johannes; Harbeck, Nadia
    Reduction of Serious Adverse Events (SAE) under palbociclib treatment in patients using an interactive eHealth system
    In: European Journal of Cancer (EJC) Jg. 138 (2020) S. S68
  • Nitz, Ulrike; Gluz, Oleg; Kreipe, Hans H.; Christgen, Matthias; Kümmel, Sherko; Baehner, Frederick L.; Shak, Steven; Aktas, Bahriye; Braun, Michael; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Nuding, Benno; Darsow, Maren; Schumacher, Claudia; Krauss, Katja; Malter, Wolfram; Thill, Marc; Warm, Mathias; Wuerstlein, Rachel; Kates, Ronald E.; Harbeck, Nadia
    The run-in phase of the prospective WSG-ADAPT HR+/HER2– trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer
    In: Therapeutic Advances in Medical Oncology Jg. 12 (2020)
  • Mayer, Ingrid A.; Prat, Aleix; Egle, Daniel; Blau, Sibel; Alejandro Perez Fidalgo, J.; Gnant, Michael; Fasching, Peter A.; Colleoni, Marco; Wolff, Antonio C.; Winer, Eric P.; Singer, Christian F.; Hurvitz, Sara; Estevez, Laura García; Van Dam, Peter A.; Kümmel, Sherko; Mundhenke, Christoph; Holmes, Frankie; Babbar, Naveen; Charbonnier, Laure; Diaz-Padilla, Ivan; Vogl, Florian D.; Sellami, Dalila; Arteaga, Carlos L.; Perez Fidalgo, Jose Alejandro; Garcia Estevez, Laura
    A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)
    In: Clinical Cancer Research Jg. 25 (2019) Nr. 10, S. 2975 - 2987
  • Bischoff, Joachim; Barinoff, Jana; Mundhenke, Christoph; Bauerschlag, Dirk O.; Costa, Serban-Dan; Herr, Daniel; Lübbe, Kristina; Marmé, Frederik; Maass, Nicolai; Von Minckwitz, Gunter; Grischke, Eva-Maria; Müller, Volkmar; Schmidt, Marcus; Gerber, Bernd; Kümmel, Sherko; Schumacher, Claudia; Krabisch, Petra; Seiler, Sabine; Thill, Marc; Nekljudova, Valentina; Loibl, Sibylle
    A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)
    In: Anti-Cancer Drugs Jg. 30 (2019) Nr. 4, S. 394 - 401
  • Wunderle, Marius; Pretscher, Jutta; Brucker, Sara Y.; Volz, Bernhard; Hartmann, Arndt; Fiessler, Cornelia; Hein, Alexander; Häberle, Lothar; Jud, Sebastian M.; Lux, Michael P.; Janni, Wolfgang; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina B.; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kümmel, Sherko; Martin, Bernhard; Thomssen, Christoph; Graf, Heiko; Wolf, Christopher; Bayer, Christian M.; Hack, Carolin C.; Almstedt, Katrin; Gass, Paul; Heindl, Felix; Brodkorb, Tobias F.; Nabieva, Naiba; Lindner, Christoph; Kolberg, Hans-Christian; Krabisch, Petra; Weigel, Michael; Steinfeld-Birg, Dieter; Kohls, Andreas; Brucker, Cosima; Schulz, Volker; Fischer, Gunnar; Pelzer, Volker; Wallwiener, Diethelm; Rack, Brigitte; Fehm, Tanja; Rody, Achim; Maass, Nicolai; Beckmann, Matthias W.; Fasching, Peter A.; Rauh, Claudia
    Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer
    In: Breast Cancer Research and Treatment Jg. 174 (2019) Nr. 2, S. 453 - 461
  • Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Wuerstlein, Rachel; Kreipe, Hans H.; Harbeck, Nadia
    Correction to: Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients : five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial
    In: Breast Cancer Research and Treatment Jg. 175 (2019) Nr. 1, S. 265 - 266
  • Haller, Heidemarie; Wang, Taige; Lauche, Romy; Choi, Kyung-Eun; Voiß, Petra; Felber, Sabine; Cramer, Holger; Ataseven, Beyhan; Kümmel, Sherko; Paul, Anna; Dobos, Gustav
    Hypoglossal acupuncture for acute chemotherapy-induced dysgeusia in patients with breast cancer : Study protocol of a randomized, sham-controlled trial
    In: Trials Jg. 20 (2019) Nr. 1, S. 398
  • Schneeweiss, Andreas; Möbus, Volker; Tesch, Hans; Hanusch, Claus; Denkert, Carsten; Lübbe, Kristina; Huober, Jens; Klare, Peter; Kümmel, Sherko; Untch, Michael; Kast, Karin; Jackisch, Christian; Thomalla, Jörg; Ingold-Heppner, Barbara; Blohmer, Jens-Uwe; Rezai, Mahdi; Frank, Matthias; Engels, Knut; Rhiem, Kerstin; Fasching, Peter Andreas; Nekljudova, Valentina; von Minckwitz, Gunter; Loibl, Sibylle
    Intense dose-dense epirubicin, paclitaxel, cyclophosphamide versus weekly paclitaxel, liposomal doxorubicin (plus carboplatin in triple-negative breast cancer) for neoadjuvant treatment of high-risk early breast cancer (GeparOcto—GBG 84) : A randomised phase III trial
    In: European Journal of Cancer (EJC) Jg. 106 (2019) S. 181 - 192
  • Voiß, Petra; Lange, Silke; Paul, Anna; Dobos, Gustav; Kümmel, Sherko
    Komplementäre Therapien in der Onkologie
    In: Der Gynäkologe Jg. 52 (2019) Nr. 2, S. 135 - 143
  • Voi, Petra; Klose, Petra; Kümmel, Sherko; Voiß, Petra
    Kurzzeitfasten unter Chemotherapie
    In: Geburtshilfe und Frauenheilkunde Jg. 79 (2019) Nr. 9, S. 937 - 939
  • Nabieva, Naiba; Häberle, Lothar; Brucker, Sara Y.; Janni, Wolfgang; Volz, Bernhard; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina-Barbara; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kümmel, Sherko; Martin, Bernhard; Thomssen, Christoph; Graf, Heiko; Wolf, Christopher; Lux, Michael P.; Bayer, Christian M.; Rauh, Claudia; Hack, Carolin C.; Almstedt, Katrin; Gass, Paul; Heindl, Felix; Brodkorb, Tobias; Lindner, Christoph; Kolberg, Hans-Christian; Krabisch, Petra; Weigel, Michael; Steinfeld-Birg, Dieter; Kohls, Andreas; Brucker, Cosima; Schulz, Volker; Fischer, Gunnar; Pelzer, Volker; Rack, Brigitte; Beckmann, Matthias W.; Fehm, Tanja; Rody, Achim; Maass, Nicolai; Hein, Alexander; Fasching, Peter A.
    Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients
    In: International Journal of Cancer Jg. 145 (2019) Nr. 8, S. 2114 - 2121
  • Nitz, Ulrike; Gluz, Oleg; Clemens, Michael; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Aktas, Bahriye; Stefek, Andrea; Pollmanns, Anke; Lorenz-Salehi, Fatemeh; Uleer, Christoph; Krabisch, Petra; Kümmel, Sherko; Liedtke, Cornelia; Shak, Steven; Wuerstlein, Rachel; Christgen, Matthias; Kates, Ronald E.; Kreipe, Hans H.; Harbeck, Nadia
    West German Study PlanB Trial : Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer
    In: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. 10, S. 799 - 808
  • Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kümmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; Von Schumann, Raquel; Harbeck, Nadia
    Comparison of Neoadjuvant Nab-Paclitaxel+Carboplatin vs Nab-Paclitaxel+Gemcitabine in Triple-Negative Breast Cancer : Randomized WSG-ADAPT-TN Trial Results
    In: Journal of the National Cancer Institute (JNCI) Jg. 110 (2018) Nr. 6, S. 628 - 637
  • Nitz, U.A.; Gluz, Oleg; Christgen, M.; Grischke, E.-M.; Augustin, D.; Kümmel, Sherko; Braun, M.; Potenberg, J.; Kohls, A.; Krauss, K.; Stefek, A.; Schumacher, C.; Forstbauer, H.; Reimer, T.; Fischer, H.; Liedtke, C.; Wuerstlein, R.; Schumacher, J.; Kates, R.; Kreipe, H.; Harbeck, N.
    De-escalation strategies in HER2-positive early breast cancer (EBC) : Final analysis of the WSG-ADAPT HER2+/HR- phase II trial: Efficacy, safety, and predictive markers for 12 weeks of neoadjuvant dual blockade with trastuzumab and pertuzumab ± weekly paclitaxel
    In: Annals of Oncology Jg. 28 (2017) Nr. 11, S. 2768 - 2772
  • Furlanetto, Jenny; Jackisch, Christian; Untch, Michael; Schneeweiss, Andreas; Schmatloch, Sabine; Aktas, Bahriye; Denkert, Carsten; Wiebringhaus, Hermann; Kümmel, Sherko; Warm, Mathias; Paepke, Stefan; Just, Marianne; Hanusch, Claus; Hackmann, John; Blohmer, Jens Uwe; Clemens, Michael; Costa, Serban Dan; Gerber, Bernd; Nekljudova, Valentina; Loibl, Sibylle; von Minckwitz, Gunter
    Efficacy and safety of nab-paclitaxel 125 mg/m² and nab-paclitaxel 150 mg/m² compared to paclitaxel in early high-risk breast cancer : Results from the neoadjuvant randomized GeparSepto study (GBG 69)
    In: Breast Cancer Research and Treatment Jg. 163 (2017) Nr. 3, S. 495 - 506
  • Hahnen, Eric; Lederer, Bianca; Hauke, Jan; Loibl, Sibylle; Kröber, Sandra; Schneeweiss, Andreas; Denkert, Carsten; Fasching, Peter A.; Blohmer, Jens U.; Jackisch, Christian; Paepke, Stefan; Gerber, Bernd; Kümmel, Sherko; Schem, Christian; Neidhardt, Guido; Huober, Jens; Rhiem, Kerstin; Costa, Serban; Altmüller, Janine; Hanusch, Claus; Thiele, Holger; Müller, Volkmar; Nürnberg, Peter; Karn, Thomas; Nekljudova, Valentina; Untch, Michael; Von Minckwitz, Gunter; Schmutzler, Rita K.
    Germline mutation status, pathological complete response, and disease-free survival in triple-negative breast cancer : Secondary analysis of the GeparSixto randomized clinical trial
    In: JAMA Oncology Jg. 3 (2017) Nr. 10, S. 1378 - 1385
  • Hack, Carolin C.; Fasching, Peter A.; Fehm, Tanja; De Waal, Johann; Rezai, Mahdi; Baier, Bernd; Baake, Gerold; Kolberg, Hans-Christian; Guggenberger, Martin; Warm, Mathias; Harbeck, Nadia; Wuerstlein, Rachel; Deuker, Jörg-Uwe; Dall, Peter; Richter, Barbara; Wachsmann, Grischa; Brucker, Cosima; Siebers, Jan W.; Fersis, Nikos; Kuhn, Thomas; Wolf, Christopher; Vollert, Hans-Walter; Breitbach, Georg-Peter; Janni, Wolfgang; Landthaler, Robert; Kohls, Andreas; Rezek, Daniela; Noesslet, Thomas; Fischer, Gunnar; Henschen, Stefan; Praetz, Thomas; Heyl, Volker; Kühn, Thorsten; Krauss, Thomas; Thomssen, Christoph; Hohn, Andre; Tesch, Hans; Mundhenke, Christoph; Hein, Alexander; Rauh, Claudia; Bayer, Christian M.; Jacob, Adib; Schmidt, Katja; Belleville, Erik; Hadji, Peyman; Brucker, Sara Y.; Wallwiener, Diethelm; Kümmel, Sherko; Beckmann, Matthias W.; Paepke, Daniela
    Interest in Integrative Medicine among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
    In: Integrative Cancer Therapies Jg. 16 (2017) Nr. 2, S. 165 - 175
  • Voiß, P.; Dobos, Gustav; Choi, K.-E.; Lange, S.; Kümmel, Sherko; Paul, Anna
    Lebensstilfaktoren und Komplementärmedizin beim Mammakarzinom
    In: Der Gynäkologe Jg. 50 (2017) Nr. 7, S. 525 - 531
  • Dobos, Gustav; Kümmel, Sherko; Voiß, P.; Choi, K.-E.; Lange, S.; Paul, Anna
    Mind-Body-Medizin in der integrativen Onkologie : Studienlage und Einsatzgebiete
    In: Der Gynäkologe Jg. 50 (2017) Nr. 1, S. 31 - 35
  • Haller, Heidemarie; Winkler, María M.; Klose, Petra; Dobos, Gustav; Kümmel, Sherko; Cramer, Holger
    Mindfulness-based interventions for women with breast cancer : an updated systematic review and meta-analysis
    In: Acta Oncologica Jg. 56 (2017) Nr. 12, S. 1665 - 1676
  • Loibl, Sibylle; de la Pena, Lorena; Nekljudova, Valentina; Zardavas, Dimitrios; Michiels, Stefan; Denkert, Carsten; Rezai, Mahdi; Bermejo, Begoña; Untch, Michael; Lee, Soo Chin; Turri, Sabine; Urban, Patrick; Kümmel, Sherko; Steger, Guenther; Gombos, Andrea; Lux, Michael; Piccart, Martine J.; Von Minckwitz, Gunter; Baselga, José; Loi, Sherene
    Neoadjuvant buparlisib plus trastuzumab and paclitaxel for women with HER2+ primary breast cancer : A randomised, double-blind, placebo-controlled phase II trial (NeoPHOEBE)
    In: European Journal of Cancer (EJC) Jg. 85 (2017) S. 133 - 145
  • Kümmel, Sherko; Paepke, Stefan; Huober, Jens; Schem, Christian; Untch, Michael; Blohmer, Jens Uwe; Eiermann, Wolfgang; Gerber, Bernd; Hanusch, Claus; Hilfrich, Jörn; Jackisch, Christian; Schneeweiss, Andreas; Denkert, Carsten; Engels, Knut; Klare, Peter; Fasching, Peter A.; von Minckwitz, Gunter; Burchardi, Nicole; Loibl, Sibylle
    Randomised, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE)
    In: European Journal of Cancer (EJC) Jg. 84 (2017) S. 1 - 8
  • Higgins, M.; Curigliano, G.; Dieras, V.; Kümmel, Sherko; Kunz, G.; Fasching, P.A.; Campone, M.; Bachelot, T.; Krivorotko, P.; Chan, S.; Ferro, A.; Schwartzberg, L.; Gillet, M.; De Sousa Alves, P.M.; Wascotte, V.; Lehmann, F.F.; Goss, P.
    Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer : a randomized Phase I study
    In: Breast Cancer Research and Treatment Jg. 162 (2017) Nr. 3, S. 479 - 488
  • Koch, Anna K.; Rabsilber, Sybille; Lauche, Romy; Kümmel, Sherko; Dobos, Gustav; Langhorst, Jost; Cramer, Holger
    The effects of yoga and self-esteem on menopausal symptoms and quality of life in breast cancer survivors : a secondary analysis of a randomized controlled trial
    In: Maturitas: The European Menopause Journal Jg. 105 (2017) S. 95 - 99
  • Schwentner, Lukas; Helms, Gisela; Nekljudova, Valentina; Ataseven, Beyhan; Bauerfeind, Ingo; Ditsch, Nina; Fehm, Tanja; Fleige, Barbara; Hauschild, Maik; Heil, J.; Kümmel, Sherko; Lebeau, Anette; Schmatloch, Sabine; Schrenk, Peter; Staebler, Anette; Loibl, Sibylle; Untch, Michael; Von Minckwitz, Gunter; Liedtke, Cornelia; Kühn, Thorsten
    Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy : Results from the multi-center SENTINA trial
    In: The Breast Jg. 31 (2017) S. 202 - 207
  • Reinisch, Mattea; Huober, Jens; von Minckwitz, Gunter; Blohmer, Jens-Uwe; Denkert, Carsten; Hanusch, Claus; Jackisch, Christian; Kümmel, Sherko; Schneeweiss, Andreas; Rhiem, Kerstin; Lederer, Bianca; Untch, Michael; Nekljudova V, Valentina; Loibl, Sibylle
    pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy : A retrospective pooled analysis of individual patients data of four German neoadjuvant trials
    In: The Breast Jg. 32 (2017) S. 73 - 78
  • Cramer, Holger; Rabsilber, Sybille; Lauche, Romy; Kümmel, Sherko; Dobos, Gustav
    Yoga and meditation for menopausal symptoms in breast cancer survivors : A randomized controlled trial
    In: Cancer Jg. 121 (2015) Nr. 13, S. 2175 - 2184
  • Reinisch, Mattea; Von Minckwitz, Gunter; Harbeck, Nadia; Janni, Wolfgang; Kümmel, Sherko; Kaufmann, Manfred; Elling, Dirk; Nekljudova, Valentina; Loibl, Sibylle
    Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer
    In: Breast Care Jg. 8 (2013) Nr. 1, S. 60 - 66
  • Hahn, Steffen; Heusner, Till; Kümmel, Sherko; Ninger, Angelika Kö; Nagarajah, James; Müller, Stefan; Boy, Christian; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Stahl, Alexander
    Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer
    In: Acta Radiologica Jg. 52 (2011) Nr. 9, S. 1009 - 1014
  • Heusner, Till Alexander; Hahn, S.; Jonkmanns, C.; Kümmel, Sherko; Otterbach, F.; Hamami, Monia; Stahl, A. R.; Bockisch, Andreas; Forsting, Michael; Antoch, G.
    Diagnostic accuracy of fused positron emission tomography/magnetic resonance mammography : Initial results
    In: The British Journal of Radiology (BJR) Jg. 84 (2011) Nr. 998, S. 126 - 135
  • Von Minckwitz, Gunter; Untch, Michael; Nüesch, Eveline; Loibl, Sibylle; Kaufmann, Manfred; Kümmel, Sherko; Fasching, Peter A.; Eiermann, Wolfgang; Blohmer, Jens-Uwe; Costa, Serban Dan; Mehta, Keyur; Hilfrich, Jörn; Jackisch, Christian; Gerber, Bernd; Du Bois, Andreas; Huober, Jens; Hanusch, Claus; Konecny, Gottfried; Fett, Werner; Stickeler, Elmar; Harbeck, Nadia; Müller, Volkmar; Jüni, Peter
    Impact of treatment characteristics on response of different breast cancer phenotypes : Pooled analysis of the German neo-adjuvant chemotherapy trials
    In: Breast Cancer Research and Treatment Jg. 125 (2011) Nr. 1, S. 145 - 156
  • Schroeder, J. K.; Kümmel, Sherko; Pietzner, Klaus; Hector, J.; Sehouli, Jalid; Chekerov, Radoslav
    Optimizing the clinical management of gynecological and breast cancer via online tumor conferences
    In: Anticancer Research Jg. 31 (2011) Nr. 8, S. 2669 - 2673
  • Blohmer, Jens-Uwe; Paepke, Stefan; Sehouli, Jalid; Boehmer, Dirk; Kolben, Martin; Würschmidt, Florian; Petry, Karl U.; Kimmig, Rainer; Elling, Dirk; Thomssen, Christoph; Von Minckwitz, Gunter; Möbus, Volker; Hinke, Axel; Kümmel, Sherko; Budach, Volker; Lichtenegger, Werner; Schmid, Peter
    Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer : Results of the NOGGO-AGO Intergroup Study
    In: Journal of Clinical Oncology (JCO) Jg. 29 (2011) Nr. 28, S. 3791 - 3797
  • Heusner, Till Alexander; Kümmel, Sherko; Köninger, Angela; Hamami, Monia; Hahn, Steffen; Quinsten, Anton; Bockisch, Andreas; Forsting, Michael; Lauenstein, Thomas; Antoch, Gerald; Stahl, Alexander
    Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging
    In: European Journal of Nuclear Medicine & Molecular Imaging Jg. 37 (2010) Nr. 6, S. 1077 - 1086
  • Umutlu, Lale; Maderwald, Stefan; Kraff, Oliver; Theysohn, Jens; Kümmel, Sherko; Hauth, Elke A.; Forsting, Michael; Antoch, Gerald; Ladd (M.), Mark E.; Quick, Harald H.; Lauenstein, Thomas
    Dynamic Contrast-Enhanced Breast MRI at 7 Tesla Utilizing a Single-loop Coil : A Feasibility Trial
    In: Academic Radiology Jg. 17 (2010) Nr. 8, S. 1050 - 1056
  • Heusner, Till Alexander; Kümmel, Sherko; Hahn, Steffen; Köninger, Angela; Otterbach, Friedrich; Hamami, Monia; Kimmig, Rainer; Forsting, Michael; Bockisch, Andreas; Antoch, Gerald; Stahl, Alexander
    Diagnostic value of full-dose FDG PET/CT for axillary lymph node staging in breast cancer patients
    In: European Journal of Nuclear Medicine and Molecular Imaging Jg. 36 (2009) Nr. 10, S. 1543 - 1550
  • Erim, Yesim; Beckmann, Mingo; Gerlach, Gabriele; Kümmel, Sherko; Oberhoff, Carsten; Senf, Wolfgang; Kimmig, Rainer
    Screening von psychischen Belastungen bei ersterkrankten Brustkrebspatientinnen : Einsatz von HADS-D und PO-Bado
    In: Zeitschrift für Psychosomatische Medizin und Psychotherapie Jg. 55 (2009) Nr. 3, S. 248 - 262
  • Abstracts

  • Harbeck, Nadia; Nitz, U.; Christgen, Matthias; Kümmel, Sherko; Braun, Michael S.; Biehl, C.M.; Schumacher, Claudia; Malter, Wolfram; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva Maria; Kolberg-Liedtke, Cornelia; de Haas, Sanne Lysbet; Deurloo, Regula J.; Kates, R.E.; Eulenburg zu, Christine; Wuerstlein, Rachel; Kreipe, Hans Heinrich; Gluz, Oleg
    Predictive impact of biomarkers on pCR and survival after de-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs. trastuzumab+ET in HER2+/HR+ early breast cancer : WSG ADAPT TP trial
    In: Annals of Oncology Jg. 32 (2021) Nr. Suppl. 5, S. 1285
  • Harbeck, N.; Nitz, Ulrike; Christgen, M.; Kümmel, Sherko; Braun, M.; Schumacher, Claudia; Potenberg, J.; Tio, Joseph; Aktas, Bahriye; Malter, W.; Forstbauer, H.; von Schumann, Raquel; Just, Marianne; Jóźwiak, Katarzyna; Hauptmann, M.; Kates, R.; Gräser, M.; Wuerstlein, Rachel; Kreipe, Hans
    LBA14 De-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs trastuzumab+ET in early HR+/HER2+ breast cancer (BC) : ADAPT-TP survival results
    In: Annals of Oncology Jg. 31 (2020) Nr. Suppl. 4, S. S1146